Company / R&D per Share
Niagen Bioscience, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.08
FY2025
5-year range
$0.06 / $0.08
FY2021-FY2025
Trend
+23.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has increased for 4 consecutive years, from $0.06 in FY2021 to $0.08 in FY2025.
Based on SEC 10-K filings.
0.08 in FY2025 with a 5-year CAGR of +2.0%.
Improved from $0.06 to $0.08 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +13.3%
- 5-Year CAGR
- +2.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- Niagen Bioscience, Inc.'s r&d per share has grown for 4 consecutive years.
- In FY2025, r&d per share increased 23.8% year-over-year.
- Peak r&d per share was recorded in FY2019.
- Lowest r&d per share in the period was in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.08 | +23.8% |
| FY2024 | $0.07 | +2.2% |
| FY2023 | $0.06 | +15.1% |
| FY2022 | $0.06 | +1.9% |
| FY2021 | $0.06 | -25.6% |
| FY2020 | $0.07 | -99.9% |
| FY2019 | $80.23 | +109422.0% |
| FY2018 | $0.07 | -31.4% |
| FY2017 | $0.11 | +52.3% |
| FY2016 | $0.07 | +727.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026